Language Select
Varian Logo

Press Releases

July 24, 2019
Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in dollars, or 13% in constant currency Total... Read more
July 11, 2019
Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY™ Guidance System, at the American Association of Physicists... Read more
July 09, 2019
Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June... Read more
July 08, 2019
Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy... Read more
July 01, 2019
Varian (NYSE: VAR) today announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of microsphere and bland embolic bead products for treating... Read more
June 26, 2019
Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date. The Company will report results for the third quarter of fiscal year 2019 after market close on... Read more
June 26, 2019
Providing cancer patients an opportunity for increased participation in their treatment, Varian (NYSE: VAR) today announced its collaboration with Tennessee Oncology for the implementation of... Read more
June 17, 2019
Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes during the closing period to the original... Read more
June 13, 2019
Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision support at the 19th International... Read more
June 12, 2019
Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the FlashForward™ Consortium. The Consortium... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations

Investor Relations Contact

Mike Bruff
SVP, Investor Relations